Oncology
News
Clinical staging of early esophageal cancer unreliable
Major Finding: Of 482 patients who went directly to surgery, 26% were downstaged, while 47% were upstaged.Data Source: A retrospective, database...
News
Survival higher with surveillance of small kidney tumors
Major Finding: After 36 months, patients were 63% less likely to have died if their tumors were managed by surveillance instead of surgery (HR, 0....
News
Shorter androgen blockade okay in localized prostate cancer
Major Finding: At 5 years, overall survival was 92% in the 36-month group and 87% in the 18-month group; disease specific survival was 98% and 96...
News
Racial gap in gastric cancer survival narrows at 3 years
Major Finding: Three-year relative conditional survival rates for Asian, black, or white patients with gastric cancer who underwent curative...
News
Capecitabine chemoradiotherapy effective in local pancreatic cancer
Major Finding: Median progression-free survival after 9 months of follow-up was 12 months in 35 patients given capecitabine plus radiotherapy...
News
Age, race impact prostate cancer risk
Major Finding: Men aged 75 years or older accounted for 12% of the population, but for 24% of intermediate-risk and 26% of high-risk disease.Data...
News
Survival shorter in young gastric cancer patients
Major Finding: Patients diagnosed with gastric adenocarcinoma before age 40 years lived a median of 5 months; older patients lived a median of 8...
News
Breast-conserving therapy improved survival over mastectomy
Major Finding: Women who underwent lumpectomy for stage I or II breast cancer were 28% less likely to die from any cause and up to 16% less likely...
News
Screen asymptomatic siblings of CRC patients
Major Finding: The prevalence of advanced colorectal neoplasms was approximately three times higher among siblings of colorectal cancer patients (...
Conference Coverage
Gene profiling predicted responses to colorectal, pancreatic cancer treatment
Major finding: Gene expression patterns identified three subtypes of stage II or III colorectal cancer with different responses to 5-FU–based...